Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Understand how zero based budgeting stacks up against traditional monthly methods and which approach best suits your financial goals.
18,282 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
When an executive sells stock, investors ask whether it signals trouble or simply personal liquidity needs. This guid...
A new AI risk assessment shows programmers face high displacement risk, upending traditional SaaS models and pressuri...
Investors are watching intuitive machines (lunr) earnings to gauge how a private space era company translates NASA co...
The SEC outlines a two-stage approach to on-chain trading, echoing lessons from the 1990s as it weighs how crypto ven...
California weighs a sweeping tax rule that would tax global income of multinationals. This piece explains why the ide...
Alphabet's Gemini 3.5 showcases bold AI ambitions, but the stock is sliding as investors reassess ROI and token-based...
With the 2026 World Cup in North America on the horizon, per-player earnings from prize money could swing widely depe...
A stock dip can be a doorway to opportunity if you approach it with a solid plan. This guide explains how to evaluate...
Fiverr International sits near a 52-week low, inviting questions about its future. This article breaks down the busin...
Two unevenly matched tech players—Amplitude and Agilysys—show how top-line growth and margins shape investor expectat...
A dramatic drop can set the stage for a smart rebound. This guide explains how to analyze a growth stock down right, ...